Concepedia

Catalina Trejo‐Becerril

CT

Statistics

Publications

22

Citations

1.7K

H-Index

18

Active since

1999

Affiliations

Instituto Nacional de Cancerología(Current)

Universidad Nacional Autónoma de México

Universidad de Cuautitlán Izcalli

Hospital de Especialidades

Catalina Trejo‐Becerril is an author at Instituto Nacional de Cancerología specializing in medicine, oncology, and pharmacology.

ORCID

Top concepts

Publications per year

1999–2017

22

Publications

22

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

Myrna Candelaria, Dolores Gallardo‐Rincón, Claudia Arce et al. · Annals of Oncology · 2007 · 249 citations

, , +7

Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.

Blanca Segura-Pacheco, Catalina Trejo‐Becerril, Enrique Pérez‐Cárdenas et al. · PubMed · 2003 · 206 citations

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Pilar Zambrano, Blanca Segura-Pacheco, Enrique Pérez‐Cárdenas et al. · BMC Cancer · 2005 · 150 citations · Full text

A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer

Claudia Arce, Carlos Pérez‐Plasencia, Aurora González‐Fierro et al. · PLoS ONE · 2006 · 144 citations · Full text

Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines

Alma Chávez‐Blanco, Carlos Pérez‐Plasencia, Enrique Pérez‐Cárdenas et al. · Cancer Cell International · 2006 · 142 citations · Full text

Rows per page

1–5 of 22